Abstract:Ethnopharmacological relevance: The prevalence of cardiovascular disease (CVD) is increasing worldwide. Despite significant improvements in novel targeted treatment agents, natural products purified from medicinal animals with minimal side effects have attracted much attention. Several native proteins explored from suck-blood leeches, such as non-thermostable hirudin and its variants, revealed potent anticoagulant activity. Traditional Chinese medicine clinics have proved that non-suck-blood leech Whitmania pigra Whitman (W. pigra) also played notable roles in CVD treatments even after decoction. However, only a few natural proteins and peptides have been identified from the fresh material of this medicinal species. Aim of the study: We aimed to purify and characterize thermostable anticoagulant proteins from W. pigra for further development of a therapeutic agent for thrombosis. Materials and methods: W. pigra crude extract was prepared by decoction in water. Anticoagulant proteins were purified by DEAE cellulose DE-52, Sephadex G-75, and reversed-phase liquid chromatography sequentially and analyzed by SDS-PAGE and LC-MS/MS for structural information. In addition, we conducted in vitro anticoagulant experiments, including plasma recalcification time (PRT) assay, fibrinolytic assay, activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), fibrinogen (Fib) assay, and cell viability assays. Furthermore, a carrageenan-induced chronic thromboembolism model was employed in ICR mice, and four coagulation factors (APTT, PT, TT, and Fib) activities were determined after intragastric administration. Results: The anticoagulant protein WP-77 has a relative molecular weight of ca. 20.8 kDa. It was effective over a broad temperature range from 20 °C to 100 °C and a pH 2-8 condition. The anticoagulant activity of WP-77 was retained after incubation with pepsin but was greatly inhibited by trypsin (P < 0.01). It significantly prolonged APTT and TT (P < 0.05) but had little effect on PT and Fib in vitro. Furthermore, WP-77 of a low concentration resulted in the recovery of injured EA.hy926 by thrombin. The protein also significantly prolonged APTT and TT (P < 0.01) and inhibited thrombus formation in carrageenan-induced thrombosis mice, demonstrating its antithrombotic effect in vivo. Conclusion: Our results suggest that WP-77 from W. pigra plays a distinct role in treating thrombotic diseases, and it is an essential substance of anticoagulant activity of non-suck-blood medicinal leeches. This thermostable anticoagulant protein could be a promising candidate for the development of clinical antithrombosis medicines.

A Novel Thrombin Inhibitory Peptide Discovered from Leech Using Affinity Chromatography Combined with Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectroscopy

Affinity Ultrafiltration and UPLC-HR-Orbitrap-MS Based Screening of Thrombin-Targeted Small Molecules with Anticoagulation Activity from Poecilobdella Manillensis

A Novel Selective Inhibitor to Thrombin-Induced Platelet Aggregation Purified from the Leech Whitmania Pigra.

Effect of Sulfotyrosine and Negatively Charged Amino Acid of Leech‐Derived Peptides on Binding and Inhibitory Activity Against Thrombin

New anticoagulant protein from medicinal leech

Purification and characterization of a novel thermostable anticoagulant protein from medicinal leech Whitmania pigra Whitman

Identification, Screening, and Comprehensive Evaluation of Novel Thrombin Inhibitory Peptides from the Hirudo Produced Using Pepsin

Characterization of active peptides derived from three leeches and comparison of their anti-thrombotic mechanisms using the tail vein thrombosis model in mice and metabonomics

A Novel Protease-Activated Receptor 1 Inhibitor from the Leech Whitmania Pigra.

Exploring a Hirudin variant from nonhematophagous leeches: Unraveling full-length sequence, alternative splicing, function, and potential as a novel anticoagulant polypeptide

Identification and Inhibitory Activity Against Α-Thrombin of a Novel Anticoagulant Peptide Derived from Oyster (crassostrea Gigas) Protein

Life without blood: Molecular and functional analysis of hirudins and hirudin-like factors of the Asian non-hematophagous leech Whitmania pigra

Identification and Characterization of Hirudin-Hn, a New Thrombin Inhibitor, from the Salivary Glands of Hirudo Nipponia

A New Peptide Thrombin Inhibitor from Streptomyces-Griseus

Quantitative Proteomics Based Bioactive Proteins Discovery and Quality Control of Medicinal Leeches.

Thrombin Inhibitory Peptides Derived from Mytilus Edulis Proteins: Identification, Molecular Docking and in Silico Prediction of Toxicity

Purification and Characterization of a Novel Anti-Coagulant from the Leech Hirudinaria Manillensis

Isolation and Characterization of a Novel Antithrombotic Peptide from Enzymatic Hydrolysate of Agkistrodon acutus Venom

A Novel Hirudin Derivative Characterized with Anti-Platelet Aggregations and Thrombin Inhibition.

The Effect of Leech Extracts on Endothelial Cell Coagulation-Related Factors and Endothelial Dysfuction-Related Molecules

An Ultrafiltration and High Performance Liquid Chromatography Coupled with Diode Array Detector and Mass Spectrometry Approach for Screening and Characterizing Thrombin Inhibitors from Rhizoma Chuanxiong.